Mein Warenkorb

Thrombopoietin R

Thrombopoietin R Molekülinformation

Englischer NameThrombopoietin receptorAnzahl der inverkehr gebrachten Arzneimittel8
Anzahl der klinischen Arzneimittel11Target-AliasCD110 Antigen,THCYT2,C-MPL,CD110,MPLV,Receptors, Thrombopoietin,MPL,TPOR,Myeloproliferative leukemia protein,Myeloproliferative Leukemia Virus Oncogene,Proto-Oncogene C-Mpl,TPO-R,MPL Proto-Oncogene, Thrombopoietin Receptor,Thrombopoietin Receptor,THPOR
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameThrombopoietin receptor
Target-AliasCD110 Antigen,THCYT2,C-MPL,CD110,MPLV,Receptors, Thrombopoietin,MPL,TPOR,Myeloproliferative leukemia protein,Myeloproliferative Leukemia Virus Oncogene,Proto-Oncogene C-Mpl,TPO-R,MPL Proto-Oncogene, Thrombopoietin Receptor,Thrombopoietin Receptor,THPOR
Anzahl der inverkehr gebrachten Arzneimittel8
Anzahl der klinischen Arzneimittel11
Höchste Forschungs- und EntwicklungsphaseApproved

Thrombopoietin R Molekülhintergrund

Thrombopoietin R, also known as TPO-R, is expressed predominantly on the surface of MKs, platelets, hemangioblasts, and hematopoietic stem cells (HSCs). Binding of TPO to the megakaryocyte TPO-R leads to different effects: prevention of megakaryocyte apoptosis; increased megakaryocyte number, size, and ploidy; increasing rate of megakaryocyte maturation; and internalization of the TPO/TPO-R complex. Thrombopoietin R involved in multiple signal transduction pathways, such as JAK, STAT, and MAP kinase.

Thrombopoietin R Molekülalias

MPL,C-MPL,CD110,MPLV,THCYT2,TPOR

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Romiplostim biosimilar (Enzene Biosciences)267639-76-9Phase 3 ClinicalEnzene Biosciences LtdPurpura, Thrombocytopenic, Idiopathic
Details
Romiplostim biosimilar (Intas Pharmaceuticals)Phase 3 ClinicalIntas BiopharmaceuticalsPurpura, Thrombocytopenic, Idiopathic
Details
Romiplostim biosimilar(Generium)GNR-069Phase 3 ClinicalCjsc GeneriumPurpura, Thrombocytopenic, Idiopathic
Details
PN-20PN20; PN-20; PJ004; PJ-004Phase 2 ClinicalChongqing Peg-Bio Biopharm Co LtdPurpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Recombinant human thrombopoietin(Peking University People's Hospital)Phase 2 ClinicalPeking University People'S HospitalParturition; Purpura, Thrombocytopenic, Idiopathic
Details
Recombinant human thrombopoietin mimetics (Shandong Quangang)Phase 2 ClinicalShandong Quangang Pharmaceutical Co LtdPurpura, Thrombocytopenic, Idiopathic
Details
PEGylated thrombopoietin (Chongqing Paijin Bio)Phase 2 ClinicalChongqing Peg-Bio Biopharm Co LtdHematologic Diseases; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Romiplostim biosimilar(Geropharma)GP-40141Phase 1 ClinicalGeropharmPurpura, Thrombocytopenic, Idiopathic
Details
SCB-219SCB-219-M; SCB-219; SCB-219MPhase 1 ClinicalClover Biopharmaceuticals LtdPurpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Recombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical)Phase 1 ClinicalBeijing Tide Pharmaceutical Co LtdPurpura, Thrombocytopenic, Idiopathic
Details
Thrombopoietin agonist (Scripps Research)3D9ClinicalThe Scripps Research Institute IncThrombocytopenia
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Recombinant human thrombopoietin biosimilar (Biolotus)ApprovedBiolotusZypotin-TPOBrazilThrombocytopeniaBiolotus2015-01-01Thrombocytopenia
Details
RomiplostimAMP-2; AMG-531ApprovedAmgen IncRomiplate, NplateUnited StatesPurpura, Thrombocytopenic, Idiopathic; ThrombocytopeniaAmgen Inc2008-08-22Acute Radiation Syndrome; Anemia, Aplastic; Bone Marrow Failure Disorders; Carcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Hodgkin Disease; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Ovarian Neoplasms; Pancytopenia; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Sarcoma, Ewing; Solid tumours; Thrombocytopenia
Details
LusutrombopagS-888711ApprovedShionogi & Co LtdMulpletaJapanThrombocytopeniaShionogi & Co Ltd2015-09-28Liver Diseases; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Herombopag OlamineSHR-8735; SHR 8735 olamineApprovedJiangsu Hengrui Medicine Co LtdHengqu, 恒曲Mainland ChinaAnemia, Aplastic; ThrombocytopeniaJiangsu Hengrui Medicine Co Ltd2021-06-16Anemia, Aplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Liver Diseases; Lung Neoplasms; Nasopharyngeal Carcinoma; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Romiplostim biosimilar (Qilu Pharmaceutical)QL-0911ApprovedQilu Pharmaceutical Co Ltd瑞立升Mainland ChinaThrombocytopeniaQilu Pharmaceutical Co Ltd2024-04-02Anemia, Aplastic; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Eltrombopag DiolamineSB-497115-GR; ETB-115; SB-497115ApprovedGlaxosmithkline PlcPromacta/Revolade, 瑞弗兰, レボレード, 特艾升, Promacta, RevoladeUnited StatesPurpura, Thrombocytopenic, IdiopathicNovartis Pharma Ag2008-11-20Anemia, Aplastic; Anemia, Diamond-Blackfan; Blood Platelet Disorders; Bone Marrow Failure Disorders; Bone marrow transplant rejection; Catheter-Related Infections; Delayed Graft Function; Fanconi Anemia; Hematologic Neoplasms; Hematopoietic stem cell transplantation (HSCT); Hemorrhage; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Leukemia; Leukemia, Basophilic, Acute; Leukemia, Eosinophilic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Liver Cirrhosis; Liver Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms, Connective and Soft Tissue; Osteosarcoma; Primary Myelofibrosis; Purpura; Purpura, Thrombocytopenic, Id
Details
Avatrombopag MaleateYM-477; AKR-501; AS-1670542; AKR-501-monomaleate; E-5501ApprovedAstellas Pharma Inc苏可欣, Doptelet, DOPTELETUnited StatesThrombocytopenia; Liver DiseasesAkarx Inc2018-05-21Anemia, Aplastic; Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Liver Diseases; Lymphoma; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
Details
Recombinant human thrombopoietinrhTPO (3SBio); TPO106; TPO-106ApprovedShenyang Sunshine Pharmaceutical Co Ltd特比奥, Tpiao, 特比澳, TebiaoMainland ChinaThrombocytopenia; Purpura, Thrombocytopenic, IdiopathicShenyang Sunshine Pharmaceutical Co Ltd2005-03-10Breast Neoplasms; Leukemia; Leukemia, Myeloid, Acute; Liver Cirrhosis; Liver Diseases; Lymphoma; Multiple Myeloma; Myelodysplastic-Myeloproliferative Diseases; Neutropenia; Plasmacytoma; Purpura, Thrombocytopenic, Idiopathic; Radiation sickness; Sepsis; Thrombocytopenia
Details
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns